Full-Time

VP – Early Clinical Research Physician

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Compensation Overview

$260k - $325kAnnually

Senior

Cambridge, MA, USA + 1 more

More locations: New York, NY, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Biology & Biotech
Required Skills
Google Cloud Platform

You match the following Schrödinger's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Strong background in strategy execution and project management with an ability to partner in the planning, development, and execution of scientific, regulatory and operational strategies
  • A high-performing physician-scientist familiar with clinical and translational research involving biomarkers and correlative laboratory clinical trial endpoints
  • M.D./Ph.D. or a MD with a focus on oncology (preferably board-certified in medical oncology or hematology/oncology) with significant scientific research experience
  • Minimum of 5 years of experience in early-phase clinical development of oncology drugs, including experience leading clinical research within the pharmaceutical industry or academia is preferred
  • Strong knowledge of clinical trial design and statistical analysis
  • Experience interacting with regulatory agencies (FDA, EMA)
  • Excellent communication skills, both written and verbal
  • Ability to work collaboratively in a fast-paced, dynamic environment
Responsibilities
  • Provide medical leadership in the design and conduct early clinical Phase 1 and Proof-of-Concept development trials, assess clinical safety and efficacy data, and write clinical study reports, clinical sections of INDs, Investigator Brochures
  • Work closely with biomarker, drug safety, clinical operations translational research scientists. You will interpret reports, prepare oral and written results of product research, and participate in the discussion and prioritization of strategies formulated within the oncology and immunology disease areas
  • Work collaboratively with the cross-functional compound development team on strategic planning, study design and execution of early-phase clinical trials, including protocol development, safety monitoring, and data analysis
  • Collaborate with translational sciences to validate potential biomarkers for patient selection and pharmacodynamic evaluation
  • Lead outreach and interactions with key opinion leaders, clinical investigators, and other key stakeholders to build relationships and ensure alignment on clinical development plans and clinical study execution
  • Provide medical oversight for clinical trials and ensure patient safety and ensure clinical trials are conducted in accordance with all relevant regulations and guidelines, including Good Clinical Practice (GCP)
  • Contribute to clinical sections of regulatory submissions and represent Schrodinger at regulatory meetings
  • Participate in the review of preclinical data and support decision-making related to drug development
  • Stay current with emerging scientific and clinical developments in oncology and translational medicine
Desired Qualifications
  • Experience leading clinical research within the pharmaceutical industry or academia is preferred

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict molecular behavior, which assists researchers in identifying potential drug candidates more efficiently. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative research and drug discovery programs, allowing for a more integrated approach to scientific research. The company's goal is to enhance scientific research and innovation by providing powerful computational resources and fostering partnerships that drive drug discovery.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Simplify Jobs

Simplify's Take

What believers are saying

  • $19.5M Gates Foundation grant boosts platform for neglected diseases, expanding market reach.
  • Predictive toxicology tools initiative could lead to safer, efficient drug development.
  • SGR-1505 discovery showcases ability to reduce drug discovery timelines significantly.

What critics are saying

  • Recursion and Exscientia merger creates strong AI-driven drug discovery competitor.
  • Avicenna's independent expansion could lead to competitive tensions with Schrödinger.
  • High R&D costs may strain resources despite Gates Foundation's $10M grant.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharma, academia, and government labs.
  • The company excels in rapid drug discovery, exemplified by SGR-1505's swift development.
  • Schrödinger's collaboration with Avicenna enhances medicinal chemistry through machine learning.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Parental Leave